Expert Opinion on Drug Delivery

Papers
(The TQCC of Expert Opinion on Drug Delivery is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatmen66
Artificial Intelligence’s role in colon-targeted drug delivery64
All eyes on semifluorinated alkanes: a comprehensive review of the influence of semifluorinated alkane eyedrops on tear film stabilization and drug delivery in dry eye disease58
A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement54
Calcium phosphate coated nanoparticles for drug delivery: where are we now?52
Iontophoresis for the cutaneous delivery of nanoentraped drugs51
Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study51
In vivo dermal delivery of bleomycin with electronic pneumatic injection: drug visualization and quantification with mass spectrometry51
How can nanoemulsions be used for photosensitizer drug delivery?50
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers f50
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery48
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges45
The quest to deliver high-dose rifampicin: can the inhaled approach help?45
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study43
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years41
Current insights into polymeric micelles for nasal drug delivery40
Nanominerals: a multifaceted biomaterial for regenerative medicine and drug delivery38
Self-assembled structures of ascorbic acid derivatives: encapsulation properties and controlled drug delivery applications38
The challenges of drug delivery to the esophagus and how to overcome them37
Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition37
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug–device combination products: case study of a formative Comparative Use Human Factors study37
Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs36
Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders35
Acetalated dextran: a novel delivery platform for particle-based vaccines34
Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery34
Innovative insight into the mechanism of enantioselective skin permeation for chiral drugs34
Future applications of self-immolative polymers in drug delivery33
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms32
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review32
Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances30
Current status and prospect for future advancements of long-acting antibody formulations30
An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery30
Novel formulations of metal-organic frameworks for controlled drug delivery30
Do the chitosan nanoparticles really augment the drugs’ transdermal fluxes: ending the debate using meta-analysis29
Engineering polycaprolactone nanowires for pharmacologic efficacy28
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery?28
Recent advances in the use of liquid crystalline nanoparticles for non-small cell lung cancer treatment27
Potential bladder cancer therapeutic delivery systems: a recent update27
A randomized crossover study assessing critical errors, preferences, and ease of use of two multidose powder inhalers27
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice27
Ferulic acid’s therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective27
Progress and potential of nanobubbles for ultrasound-mediated drug delivery27
Silica nanoparticles for brain cancer27
Are stimuli-responsive hybrid copolymer nanoparticles the next innovation in tumor drug delivery?26
Solvent-exchange-based in situ forming implants: advances and challenges as long-lasting formulations25
Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing25
Current insights into drug-coated balloons for peripheral arterial disease25
3D printed dosage forms, where are we headed?24
Can radiopharmaceuticals be delivered by quantum dots?24
Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery24
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders24
Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles23
An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems23
Treating glioblastoma with dextrin-based polymers23
Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices23
Understanding the interaction forces between shield-triggered autoinjectors and skin: an in-depth noninvasive study23
Platelets for advanced drug delivery in cancer22
Intramuscular injection of palmitic acid-conjugated Exendin-4 loaded multivesicular liposomes for long-acting and improving in-situ stability22
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product22
Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo22
Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application22
Polyphosphoester cubosomes: introducing a novel drug delivery system21
Inhalation delivery of nucleic acid gene therapies in preclinical drug development21
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges21
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development21
Future applications of cyclic antimicrobial peptides in drug delivery21
Recent advances in antibacterial nanoformulations for endodontic applications21
3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives20
Particle surface coating for dry powder inhaler formulations20
Lipid-based nanosystems for wound healing20
Pediatric inhalation therapy and the aerodynamic rationale for age-based aerosol sizes20
Targeted transport of biotherapeutics at the blood-brain barrier20
Is electroporation the key to drug delivery in drug-resistant cancers?20
Microneedles for oral mucosal delivery – Current trends and perspective on future directions19
Topical drug delivery to the retina: obstacles and routes to success19
Recent advances in drug delivery to the central nervous system by inhalation19
Untethered shape-changing devices in the gastrointestinal tract19
Development and approval of novel injectables: enhancing therapeutic innovations19
An update on cell-penetrating peptides with intracellular organelle targeting18
Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen18
Biphasic drug release from electrospun structures18
Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment17
Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration17
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier17
An evolving perspective on novel modified release drug delivery systems for inhalational therapy17
Polymer-based thermoresponsive hydrogels for controlled drug delivery17
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids17
Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity17
Drug delivery and formulation development of hesperidin: a systematic review17
Drug and stem cells delivery to salivary glands – a concise review16
An interview with professor Dermot O’Toole by Zoe Kenney, commissioning editor16
Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases16
The impact of common pharmaceutical excipients on the gut microbiota16
Nano-drug delivery system of natural products for disease prevention and treatment16
Recent developments in nanofiber-based fast-disintegrating drug delivery systems16
Infusion-based drug delivery to the brain: what’s next?16
Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer16
An update on the latest strategies in retinal drug delivery16
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities15
Inhaled antifungal therapy: benefits, challenges, and clinical applications15
A fluid and particle mechanics perspective of nasal drug delivery15
Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework15
Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier15
GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy14
The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices14
Correction14
Engineering trafficking pathways to overcome immunosuppressive barriers in solid tumor immunotherapy14
Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy14
Future outcomes and current limitations of injectable implants for vocal fold scarring14
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery14
Development of ROS-responsive liposomes toward targeted drug delivery14
Breast cancer epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting14
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods14
Explicit analysis of in vivo , meterological and statistical hurdles in successful clinical translation of targeted nanomedicines and plausible remedial 14
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance13
Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations13
Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence13
Advances in plasmonic-based MOF composites, their bio-applications, and perspectives in this field13
Advanced nano-delivery systems in H. pylori eradication: targeting, efficacy, and clinical translation13
Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS13
Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy13
Biopredictive tools for the development of injectable drug products13
Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics12
Development of an intranodal drug delivery system using a mouse model with lymphadenopathy: novel discoveries and clinical application12
Bovine serum albumin nanoparticles: a promising platform for nasal drug delivery12
Improving antifungal lipid-based drug delivery against Candida : a review12
Next-generation viral nanoparticles for targeted delivery of therapeutics: Fundamentals, methods, biomedical applications, and challenges12
Solid lipid nanoparticles: a promising tool for insulin delivery12
Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines12
The pursuit of linear dosage in pharmacy: reservoir-based drug delivery systems from macro to micro scale12
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis12
Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities12
The potential of a high efficacy single shot injection of artemisinin combination for effective antimalarial therapy12
Advances in engineering and delivery strategies for cytokine immunotherapy12
0.14057302474976